Advent Capital Management Sarepta Therapeutics, Inc. Transaction History
Advent Capital Management
- $93.8 Million
- Q2 2024
A detailed history of Advent Capital Management transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Advent Capital Management holds 10,000 shares of SRPT stock, worth $1.26 Million. This represents 1.69% of its overall portfolio holdings.
Number of Shares
10,000
Previous 20,000
50.0%
Holding current value
$1.26 Million
Previous $2.59 Million
38.97%
% of portfolio
1.69%
Previous 3.64%
Shares
6 transactions
Others Institutions Holding SRPT
# of Institutions
557Shares Held
85.6MCall Options Held
3.67MPut Options Held
1.75M-
Black Rock Inc. New York, NY10.3MShares$1.3 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.04MShares$1.14 Billion0.03% of portfolio
-
Capital International Investors Los Angeles, CA4.32MShares$544 Million0.14% of portfolio
-
State Street Corp Boston, MA4.14MShares$522 Million0.03% of portfolio
-
Janus Henderson Group PLC London, X03.82MShares$481 Million0.33% of portfolio
About Sarepta Therapeutics, Inc.
- Ticker SRPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,567,904
- Market Cap $11B
- Description
- Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...